In a prospective study of patients with chronic HCV genotype @a infection and cirrhosis ( @ % African American and @ % prior null responders ) , a @-week regimen of simeprevir and sofosbuvir produced a significantly higher rate of SVR@ and was better tolerated , with a lower viral relapse rate , than a @-week regimen of peginterferon , ribavirin , and sofosbuvir .